ATLASATLAS fair value
ATLAS has no fair value for this stock today.
LivsMed (491000.KQ)
LivsMed stock price today, ATLAS forecast and fair value
Healthcare · Medical Devices · KOSDAQ · South Korea
₩37,100▲ +1.50%
Prices as of Oct 27, 2026 · KRW
Chance of rising in 1 month
43%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on LivsMed in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On LivsMed
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives LivsMed a 43% chance of finishing higher a month from now (21 trading sessions) than today: somewhat worse than a coin flip.
In half of the simulated outcomes the price ends between ₩29,249 and ₩42,932; in 9 out of 10, between ₩20,815 and ₩60,330. Estimated annual volatility is 112%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- ₩840B
- Market cap (USD)
- $633M
- 52-week high
- ₩95,900
- 52-week low
- ₩27,100
- Revenue (12 months)
- ₩52.8B
- Gross margin
- 50.1%
- Operating margin
- -97.5%
- Net margin
- -50.2%
What this means
ATLAS does not publish a fair value for 491000.KQ right now, but it does show its odds of rising: somewhat worse than a coin flip.
Over the last 52 weeks 491000.KQ has traded between ₩27,100 and ₩95,900. Today it is 61.3% below that high and 37% above its low.
About the company
Livsmed Inc. engages in the research, development, manufacture, exports, and import of electro-diagnostic and electro-therapeutic apparatuses medical devices in South Korea.
Want to see everything about LivsMed?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does LivsMed do?
Livsmed Inc. engages in the research, development, manufacture, exports, and import of electro-diagnostic and electro-therapeutic apparatuses medical devices in South Korea.
What is the chance 491000.KQ goes up next month?
43%: somewhat worse than a coin flip. In half of the simulated outcomes, 491000.KQ ends the month between ₩29,249 and ₩42,932.
How big is LivsMed and what is its P/E ratio?
LivsMed's market capitalization is ₩840B. We do not show a P/E because it has no positive earnings to base one on.
How volatile is 491000.KQ?
ATLAS estimates annual volatility at 112%. In a typical month, half of the outcomes end between ₩29,249 and ₩42,932.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer